331 related articles for article (PubMed ID: 20818501)
1. Identification of CYP21A2 mutant alleles in Czech patients with 21-hydroxylase deficiency.
Vrzalová Z; Hrubá Z; St'ahlová Hrabincová E; Pouchlá S; Votava F; Kolousková S; Fajkusová L
Int J Mol Med; 2010 Oct; 26(4):595-603. PubMed ID: 20818501
[TBL] [Abstract][Full Text] [Related]
2. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
3. Chimeric CYP21A1P/CYP21A2 genes identified in Czech patients with congenital adrenal hyperplasia.
Vrzalová Z; Hrubá Z; Hrabincová ES; Vrábelová S; Votava F; Koloušková S; Fajkusová L
Eur J Med Genet; 2011; 54(2):112-7. PubMed ID: 20970527
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
[TBL] [Abstract][Full Text] [Related]
6. Investigation of CYP21A2 mutations in Turkish patients with 21-hydroxylase deficiency and a novel founder mutation.
Toraman B; Ökten A; Kalay E; Karagüzel G; Dinçer T; Açıkgöz EG; Karagüzel A
Gene; 2013 Jan; 513(1):202-8. PubMed ID: 23142378
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the association of HLA alleles and haplotypes with CYP21A2 mutations in a large cohort of patients with congenital adrenal hyperplasia.
Jayakrishnan R; Lao Q; Adams SD; Ward WW; Merke DP
Gene; 2019 Mar; 687():30-34. PubMed ID: 30419250
[TBL] [Abstract][Full Text] [Related]
8. Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.
Oh Y; Park SW; Chun SM; Lim N; Ahn KS; Ka JO; Jin DK; Han BD
Mol Diagn Ther; 2009 Dec; 13(6):397-405. PubMed ID: 19925038
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations.
Milacic I; Barac M; Milenkovic T; Ugrin M; Klaassen K; Skakic A; Jesic M; Joksic I; Mitrovic K; Todorovic S; Vujovic S; Pavlovic S; Stojiljkovic M
J Endocrinol Invest; 2015 Nov; 38(11):1199-210. PubMed ID: 26233337
[TBL] [Abstract][Full Text] [Related]
10. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
[TBL] [Abstract][Full Text] [Related]
11. Erroneous prenatal diagnosis of congenital adrenal hyperplasia owing to a duplication of the CYP21A2 gene.
Lekarev O; Tafuri K; Lane AH; Zhu G; Nakamoto JM; Buller-Burckle AM; Wilson TA; New MI
J Perinatol; 2013 Jan; 33(1):76-8. PubMed ID: 23269230
[TBL] [Abstract][Full Text] [Related]
12. Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera.
Lao Q; Burkardt DD; Kollender S; Faucz FR; Merke DP
Mol Genet Genomic Med; 2023 Jul; 11(7):e2195. PubMed ID: 37157918
[TBL] [Abstract][Full Text] [Related]
13. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency.
Chen W; Xu Z; Sullivan A; Finkielstain GP; Van Ryzin C; Merke DP; McDonnell NB
Clin Chem; 2012 Feb; 58(2):421-30. PubMed ID: 22156666
[TBL] [Abstract][Full Text] [Related]
14. Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.
Concolino P; Costella A
Mol Diagn Ther; 2018 Jun; 22(3):261-280. PubMed ID: 29450859
[TBL] [Abstract][Full Text] [Related]
15. A new CYP21A2 nonsense mutation causing severe 21-hydroxylase deficiency.
Concolino P; Minucci A; Mello E; Zuppi C; Capoluongo E
Clin Chem Lab Med; 2009; 47(7):824-5. PubMed ID: 19499972
[TBL] [Abstract][Full Text] [Related]
16. A rare CYP21A2 mutation in a congenital adrenal hyperplasia kindred displaying genotype-phenotype nonconcordance.
Khattab A; Yuen T; Al-Malki S; Yau M; Kazmi D; Sun L; Harbison M; Haider S; Zaidi M; New MI
Ann N Y Acad Sci; 2016 Jan; 1364(1):5-10. PubMed ID: 26291314
[TBL] [Abstract][Full Text] [Related]
17. Phenotype heterogeneity of congenital adrenal hyperplasia due to genetic mosaicism and concomitant nephrogenic diabetes insipidus in a sibling.
Kor Y; Zou M; Al-Rijjal RA; Monies D; Meyer BF; Shi Y
BMC Med Genet; 2018 Jul; 19(1):115. PubMed ID: 29996815
[TBL] [Abstract][Full Text] [Related]
18. A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency.
Parajes S; Quinterio C; Domínguez F; Loidi L
Clin Chem; 2007 Sep; 53(9):1577-84. PubMed ID: 17634211
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of copy number variation of
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3765-3769. PubMed ID: 31874511
[No Abstract] [Full Text] [Related]
20. High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency.
Parajes S; Quinteiro C; Domínguez F; Loidi L
PLoS One; 2008 May; 3(5):e2138. PubMed ID: 18478071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
